Instrumentation gets together with Optical Sensors:
This article was originally published in Clinica
The Italian company Instrumentation Laboratory and Optical Sensors of the US have agreed a seven-year partnership to distribute the Gem SensiCath and Gem OpticalCAM hospital point-of-care diagnostic products and their established line of critical care products. According to the companies, the non-glucose meter POC market was worth $300 million in 1996 and is set to reach $800 million by 2001. The arrangement with Instrumentation does not affect Optical's current arrangements with Hewlett-Packard, Marquette and SpaceLabs, which will continue to sell SensiCath arterial blood gas monitoring.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.